118 related articles for article (PubMed ID: 38065749)
1. Value of Contrast-Enhanced Microflow Imaging in Diagnosis of Breast Masses in Comparison with Contrast-Enhanced Ultrasound.
Luo R; Wang Q; Zhang Y; Jiang W; Wang Y; Luo Y
Acad Radiol; 2023 Dec; ():. PubMed ID: 38065749
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
Park AY; Kwon M; Woo OH; Cho KR; Park EK; Cha SH; Song SE; Lee JH; Cha J; Son GS; Seo BK
Korean J Radiol; 2019 May; 20(5):759-772. PubMed ID: 30993927
[TBL] [Abstract][Full Text] [Related]
3. Value of micro-flow imaging and high-definition micro-flow imaging in differentiating malignant and benign breast lesions.
Luo R; Zhang Y; Jiang W; Wang Y; Luo Y
Clin Radiol; 2024 Jan; 79(1):e48-e56. PubMed ID: 37932209
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of contrast-enhanced ultrasound in breast lesions of BI-RADS 4].
Liang YC; Jia CM; Xue Y; Lü Q; Chen F; Wang JJ
Zhonghua Yi Xue Za Zhi; 2018 May; 98(19):1498-1502. PubMed ID: 29804418
[No Abstract] [Full Text] [Related]
5. Diagnosis of Benign and Malignant BI-RADS 4 Breast Masses by Contrastenhanced Ultrasound Combined with Shear Wave Elastography.
Weng L; Yu M
Curr Med Imaging; 2023 Oct; ():. PubMed ID: 37921152
[TBL] [Abstract][Full Text] [Related]
6. The value of contrast-enhanced ultrasound in the diagnosis of BI-RADS-US 4a lesions less than 2 cm in diameter.
Yu MQ; Zhang LL; Jiang LP; Zhou AY
Clin Hemorheol Microcirc; 2023; 83(3):195-205. PubMed ID: 35599475
[TBL] [Abstract][Full Text] [Related]
7. Breast non-mass-like lesions on contrast-enhanced ultrasonography: Feature analysis, breast image reporting and data system classification assessment.
Xu P; Yang M; Liu Y; Li YP; Zhang H; Shao GR
World J Clin Cases; 2020 Feb; 8(4):700-712. PubMed ID: 32149054
[TBL] [Abstract][Full Text] [Related]
8. Role of Superb Microvascular Imaging in Differentiating Between Malignant and Benign Solid Breast Masses.
Diao X; Zhan J; Chen L; Chen Y; Cao H
Clin Breast Cancer; 2020 Dec; 20(6):e786-e793. PubMed ID: 32863154
[TBL] [Abstract][Full Text] [Related]
9. The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.
Zhang F; Jin L; Li G; Jia C; Shi Q; Du L; Wu R
Br J Radiol; 2021 Apr; 94(1120):20200880. PubMed ID: 33560894
[TBL] [Abstract][Full Text] [Related]
10. Principal component regression-based contrast-enhanced ultrasound evaluation system for the management of BI-RADS US 4A breast masses: objective assistance for radiologists.
Lin ZM; Chen JF; Xu FT; Liu CM; Chen JS; Wang Y; Zhang C; Huang PT
Ultrasound Med Biol; 2021 Jul; 47(7):1737-1746. PubMed ID: 33838937
[TBL] [Abstract][Full Text] [Related]
11. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
Du YR; Wu Y; Chen M; Gu XG
Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
[TBL] [Abstract][Full Text] [Related]
12. Value of contrast-enhanced malignancy imaging features in secondary grade diagnosis of BI-RADS-US type 4 breast lesions.
Gao J; Han W; Ai Si Mu Tu La DLMT; Hou X; Li ZM; Song T
Tumori; 2021 Oct; 107(5):424-431. PubMed ID: 33124515
[TBL] [Abstract][Full Text] [Related]
13. The Utility of the Fifth Edition of the BI-RADS Ultrasound Lexicon in Category 4 Breast Lesions: A Prospective Multicenter Study in China.
Gu Y; Tian JW; Ran HT; Ren WD; Chang C; Yuan JJ; Kang CS; Deng YB; Wang H; Luo BM; Guo SL; Zhou Q; Xue ES; Zhan WW; Zhou Q; Li J; Zhou P; Zhang CQ; Chen M; Gu Y; Xu JF; Chen W; Zhang YH; Wang HQ; Li JC; Wang HY; Jiang YX
Acad Radiol; 2022 Jan; 29 Suppl 1():S26-S34. PubMed ID: 32768352
[TBL] [Abstract][Full Text] [Related]
14. Microvascular architecture of breast lesions: evaluation with contrast-enhanced ultrasonographic micro flow imaging.
Du J; Li FH; Fang H; Xia JG; Zhu CX
J Ultrasound Med; 2008 Jun; 27(6):833-42; quiz 844. PubMed ID: 18499843
[TBL] [Abstract][Full Text] [Related]
15. Contrast-Enhanced Ultrasound Imaging of Breast Masses: Adjunct Tool to Decrease the Number of False-Positive Biopsy Results.
Lee SC; Tchelepi H; Grant E; Desai B; Luo C; Groshen S; Hovanessian-Larsen L
J Ultrasound Med; 2019 Sep; 38(9):2259-2273. PubMed ID: 30597640
[TBL] [Abstract][Full Text] [Related]
16. BI-RADS 4 breast lesions: could multi-mode ultrasound be helpful for their diagnosis?
Liu G; Zhang MK; He Y; Liu Y; Li XR; Wang ZL
Gland Surg; 2019 Jun; 8(3):258-270. PubMed ID: 31328105
[TBL] [Abstract][Full Text] [Related]
17. Clinical diagnostic value of contrast-enhanced ultrasound combined with microflow imaging in benign and malignant renal tumors: A retrospective cohort study.
Kuang X; Wang H; Chai W; Yuan H; He T; Shi M; Jiang T
Biomol Biomed; 2024 Apr; ():. PubMed ID: 38613844
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of conventional ultrasound combined with contrast-enhanced ultrasound in the evaluation of BI-RADS 4 lesions detected by magnetic resonance imaging.
Guo W; Li F; Jia C; Wang T; Zhang X; Yao G; Shi X; Bai M
Br J Radiol; 2022 Aug; 95(1136):20220025. PubMed ID: 35604699
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of diagnostic efficacy of multimode ultrasound in BI-RADS 4 breast neoplasms and establishment of a predictive model.
Chen Y; Lu J; Li J; Liao J; Huang X; Zhang B
Front Oncol; 2022; 12():1053280. PubMed ID: 36505867
[TBL] [Abstract][Full Text] [Related]
20. Value of ultrasound elastography combined with contrast-enhanced ultrasound and micro-flow imaging in differential diagnosis of benign and malignant breast lesions.
Ding Z; Liu W; He N; Ma X; Fu L; Ye L
Am J Transl Res; 2021; 13(12):13941-13949. PubMed ID: 35035735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
